STAT

STAT STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We dissect crucial discoveries.

We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all.

A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating un...
12/12/2025

A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating uncomplicated urogenital gonorrhea, a study published Thursday in The…

A single-dose oral antibiotic from a new class of drugs was as effective as the previous standard of care at treating uncomplicated urogenital gonorrhea,

Høeg is set to become the fifth head of the FDA's drug center in a year.
12/11/2025

Høeg is set to become the fifth head of the FDA's drug center in a year.

Høeg is set to become the fifth head of the FDA's drug center in a year.

This week on "The Readout LOUD": Is a new obesity drug making people lose too much weight? Plus catch up on and hear h...
12/11/2025

This week on "The Readout LOUD": Is a new obesity drug making people lose too much weight? Plus catch up on and hear how the country's scientific institutions have…

This week on "The Readout LOUD": Is a new obesity drug making people lose too much weight? Plus catch up on and hear how the country's scientific institutions have had a bruising year.

FDA approves new drug to treat gonorrhea, which is notorious for developing resistance to medicines
12/11/2025

FDA approves new drug to treat gonorrhea, which is notorious for developing resistance to medicines

FDA approves new drug to treat gonorrhea, which is notorious for developing resistance to medicines

Stories from the frontlines of Trump's attack on science: Follow-ups from a year of struggles in Part 8 of our series "A...
12/11/2025

Stories from the frontlines of Trump's attack on science: Follow-ups from a year of struggles in Part 8 of our series "American Science, Shattered."

Stories from the frontlines of Trump's attack on science: Follow-ups from a year of struggles in Part 7 of our series "American Science, Shattered."

Democratic and Republican proposals on health insurance voted down as year-end expiration of subsidies draws closer.
12/11/2025

Democratic and Republican proposals on health insurance voted down as year-end expiration of subsidies draws closer.

Democratic and Republican proposals on health insurance voted down as year-end expiration of subsidies draws closer.

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential medical conference.
12/11/2025

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential medical conference.

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential medical conference.

And more health news from the Morning Rounds newsletter
12/11/2025

And more health news from the Morning Rounds newsletter

And more health news from the Morning Rounds newsletter

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.
12/11/2025

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

European policymakers unveiled an agreement for the biggest shakeup to E.U. pharmaceutical policy in two decades.

In today's Pharmalittle roundup, Lilly's new obesity drug, E.U. pharma rules, and much more.
12/11/2025

In today's Pharmalittle roundup, Lilly's new obesity drug, E.U. pharma rules, and much more.

In today's Pharmalittle roundup, Lilly's new obesity drug, E.U. pharma rules, and much more.

In this edition of STAT Health Tech: Takeaways from top HHS officials attending a health AI summit, and other news.
12/11/2025

In this edition of STAT Health Tech: Takeaways from top HHS officials attending a health AI summit, and other news.

In this edition of STAT Health Tech: Takeaways from top HHS officials attending a health AI summit, and other news.

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losin...
12/11/2025

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

Address

1 Exchange Place
Boston, MA
02120

Opening Hours

Monday 9am - 5:30pm
Tuesday 9am - 5:30pm
Wednesday 9am - 5:30pm
Thursday 9am - 5:30pm
Friday 9am - 5:30pm

Website

Alerts

Be the first to know and let us send you an email when STAT posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category